Jul 30, 2024 / 08:30PM GMT
Operator
Good day and thank you for standing by. Welcome to the GeneDX second quarter 2024 earnings conference call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session to ask a question. During this session, you'll need to press star one one on your telephone You will then hear an automated message. Advising your hand is raised to withdraw your question, please press star one one. Again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to Sabrina Dunbar, Investor Relations. Please go ahead.
Sabrina Dunbar - GeneDx Holdings corp - Investor Relations
Thank you, Operator, and thank you to everyone for joining us today. On the call, we have Katherine Stueland, President and Chief Executive Officer; and Kevin Feeley, Chief Financial Officer.
Earlier today, GeneDx released financial results for the second quarter ended June 30, 2024. Before we begin, please take note of our cautionary statement. We may make forward-looking
Q2 2024 GeneDx Holdings Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
